Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Revenue

Phathom Pharmaceuticals had revenue of $39.50M in the quarter ending June 30, 2025, with 439.36% growth. This brings the company's revenue in the last twelve months to $114.04M, up 1,049.82% year-over-year. In the year 2024, Phathom Pharmaceuticals had annual revenue of $55.25M with 8,001.47% growth.

• Revenue (ttm): $114.04M
• Revenue Growth: +1,049.82%
• P/S Ratio: 6.44
• Revenue / Employee: $267,070
• Employees: 427
• Market Cap: 729.91M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	55.25M	54.57M	8,001.47%
Dec 31, 2023	682.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.